A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy（REACH-DMD）

Clinical trial NCT04587908 · COMPLETED

Trial details

NCT number: NCT04587908
Sponsor: Taiho Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy

Start date: 2020-11-01
Primary completion: 2026-06-18
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.